Skip to main content
. 2021 Oct 1;26(10):5888–5898. doi: 10.1038/s41380-021-01263-2

Fig. 2. Correlations between CSF and imaging (PET and MRI) biomarkers across diagnostic groups.

Fig. 2

A = PET amyloid-β 18F-florbetapir PET and 18F-florbetaben levels; AD = Alzheimer’s disease; CN = cognitively normal; EMCI = early MCI; LMCI = late MCI; MCI = mild cognitive impairment; ROI = region of interest; SMC = subjective memory concern; T = PET tau 18F-flortaucipir level; T1 = T measured in the temporal meta-ROI; T2 = T measured in the inferior temporal cortex ROI; T3 = T measured in the entorhinal cortex ROI; N1 = neurodegeneration measured as hippocampal volume adjusted for intracranial volume.